SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies

NCT05039944 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Company research strategy adjustment

Conditions

Colorectal Cancer

Interventions

DRUG: SI-B001
DRUG: Irinotecan
DRUG: FOLFIRI Protocol
DRUG: FOLFOX Protocol

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.